The Lynx Group

PMO Interview with the Innovator Series

PMO Interview with the Innovator Series: Volume 5

Michael Pellini, President and Chief Executive Officer of Foundation Medicine, offers a definition of personalized medicine in this new video series from Personalized Medicine in Oncology.

Michael Pellini, MD

Video Categories: PMO Interview with the Innovator Series

PMO Interview with the Innovator Series: Volume 4

Tom Reynolds, Chief Medical Officer of Seattle Genetics, offers a definition of personal medicine in this new video series from Personalized Medicine in Oncology.

Thomas C. Reynolds, MD, PhD

Video Categories: PMO Interview with the Innovator Series

PMO Interview with the Innovator Series: Volume 3

Kim Popovits, Chairman, CEO and President, Genomic Health Inc., offers a definition of personal medicine in the first segment of this new video from Personalized Medicine in Oncology.

Kimberly J. Popovits

Video Categories: PMO Interview with the Innovator Series

PMO Interview with the Innovator Series: Volume 2

The publishers of Personalized Medicine in Oncology (PMO) invite you to watch an interview with Peter Hirth, PhD, Chief Executive Officer of Plexxikon. In part one, Dr. Hirth discusses the use of biomarkers, segmenting the population of melanoma patients into subsets, and other aspects of personalized medicine.

Peter Hirth, PhD

Video Categories: PMO Interview with the Innovator Series

PMO Interview with the Innovator Series: Volume 1

Deborah Dunsire, MD, President and CEO of Millennium: The Takeda Oncology Company, and Kathy Giusti, Founder and CEO of the Multiple Myeloma Research Foundation, discuss the issues and vision in improving personalized medicine strategies for patients with multiple myeloma.Deborah Dunsire, MD, is the former President and CEO of Millennium Pharmaceuticals, [ Read More ]

Video Categories: PMO Interview with the Innovator Series

Sign me up!